Approval · Notice of Compliance 7604 · 2005
IMMUCYST: Notice of Compliance 7604
Issued November 8, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7604
- Date
- November 8, 2005
- Company
- Sanofi Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMMUCYST | 02194376 | Cancelled Post Market |
Medicinal ingredients
- BACILLUS CALMETTE-GUERIN (BCG) SUBSTRAIN CONNAUGHT 81 MG per VIAL